Identification of ETA and ETB binding domains using ET-derived photoprobes.

[1]  A. Ruoho,et al.  Identification of the Substrate Binding Region of Vesicular Monoamine Transporter-2 (VMAT-2) Using Iodoaminoflisopolol as a Novel Photoprobe , 2007, Molecular Pharmacology.

[2]  D. C. Chiara,et al.  [3H]Benzophenone photolabeling identifies state-dependent changes in nicotinic acetylcholine receptor structure. , 2007, Biochemistry.

[3]  A. Hajipour,et al.  Characterization of the cocaine binding site on the sigma-1 receptor. , 2007, Biochemistry.

[4]  Christophe D. Proulx,et al.  Photolabelling the urotensin II receptor reveals distinct agonist- and partial-agonist-binding sites. , 2007, The Biochemical journal.

[5]  R. Leduc,et al.  The Active and the Inactive Form of the hAT1 Receptor Have an Identical Ligand-Binding Environment: An MPA Study on a Constitutively Active Angiotensin II Receptor Mutant , 2006, Journal of receptor and signal transduction research.

[6]  Pierre Lavigne,et al.  Determining the Environment of the Ligand Binding Pocket of the Human Angiotensin II Type I (hAT1) Receptor Using the Methionine Proximity Assay* , 2005, Journal of Biological Chemistry.

[7]  A. Fournier,et al.  Transmembrane domain V of the endothelin-A receptor is a binding domain of ETA-selective TTA-386-derived photoprobes. , 2005, Biochemistry.

[8]  A. Fournier,et al.  Photolabeling study of the ligand binding domain of natriuretic peptide receptor A: development of a model. , 2005, Biochemistry.

[9]  A. Fournier,et al.  Identification of a binding domain of the endothelin-B receptor using a selective IRL-1620-derived photoprobe. , 2004, Biochemistry.

[10]  T. Masaki.  Historical review: Endothelin. , 2004, Trends in pharmacological sciences.

[11]  M. Létourneau,et al.  Development of agonists of endothelin‐1 exhibiting selectivity towards ETA receptors , 2003, British journal of pharmacology.

[12]  B. Wallace,et al.  Modeling and docking the endothelin G-protein-coupled receptor. , 2000, Biophysical journal.

[13]  P. Vichi,et al.  Transmembrane Helix 7 of the Endothelin B Receptor Regulates Downstream Signaling* , 1999, The Journal of Biological Chemistry.

[14]  A. A. D. Artiñano,et al.  HIGHLIGHTS ON ENDOTHELINS: A REVIEW , 1997 .

[15]  G. Tsujimoto,et al.  Truncation of the receptor carboxyl terminus impairs membrane signaling but not ligand binding of human ETB endothelin receptor. , 1995, Biochemical and biophysical research communications.

[16]  C. Broger,et al.  Separable binding sites for the natural agonist endothelin-1 and the non-peptide antagonist bosentan on human endothelin-A receptors. , 1995, European journal of biochemistry.

[17]  C. Miyamoto,et al.  Ligand binding domain of the human endothelin-B subtype receptor. , 1995, Protein expression and purification.

[18]  J. Tam,et al.  D-amino acid scan of endothelin: importance of amino acids adjacent to cysteinyl residues in isomeric selectivity. , 1995, Peptide research.

[19]  E. Liu,et al.  Aspartate mutation distinguishes ETA but not ETB receptor subtype‐selective ligand binding while abolishing phospholipase C activation in both receptors , 1995, FEBS letters.

[20]  R. W. Janes,et al.  A comparison of X‐ray and NMR structures for human endothelin‐1 , 1995, Protein science : a publication of the Protein Society.

[21]  J. Tam,et al.  Alanine scan of endothelin: Importance of aromatic residues , 1994, Peptides.

[22]  J. Novotný,et al.  Mutation of peptide binding site in transmembrane region of a G protein-coupled receptor accounts for endothelin receptor subtype selectivity. , 1994, The Journal of biological chemistry.

[23]  T. Watanabe,et al.  Human endothelin receptor ETB. Amino acid sequence requirements for super stable complex formation with its ligand. , 1994, The Journal of biological chemistry.

[24]  C. Miyamoto,et al.  Identification of a ligand-binding site of the human endothelin-A receptor and specific regions required for ligand selectivity. , 1994, European journal of biochemistry.

[25]  E. Liu,et al.  Structure-activity studies of endothelin leading to novel peptide ETA antagonists. , 1993, Bioorganic & medicinal chemistry.

[26]  K. Nakao,et al.  Distinct subdomains of human endothelin receptors determine their selectivity to endothelinA-selective antagonist and endothelinB-selective agonists. , 1993, The Journal of biological chemistry.

[27]  C. Miyamoto,et al.  Identification of a domain of ETA receptor required for ligand binding , 1992, FEBS letters.

[28]  A. Egloff,et al.  Replacement of lysine‐181 by aspartic acid in the third transmembrane region of endothelin type B receptor reduces its affinity to endothelin peptides and sarafotoxin 6c without affecting G protein coupling , 1992, Journal of cellular biochemistry.

[29]  Y. Urade,et al.  A reversible radioligand specific for the ETB receptor: [125I]Tyr13-Suc-[Glu9,Ala11,15]-endothelin-1(8- 21), [125I]IRL 1620. , 1992, Biochemical and biophysical research communications.

[30]  J. Pelton,et al.  The role of the disulphide bonds in endothelin‐1 , 1991, The Journal of pharmacy and pharmacology.

[31]  S. Nakanishi,et al.  Cloning and expression of a cDNA encoding an endothelin receptor , 1990, Nature.

[32]  T. Sakurai,et al.  Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor , 1990, Nature.

[33]  H. Kuroda,et al.  Structure-activity relationship of endothelin: importance of charged groups. , 1989, Biochemical and biophysical research communications.

[34]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[35]  T. Masaki,et al.  Structural basis of the function of endothelin receptor , 2004, Molecular and Cellular Biochemistry.

[36]  T. Watanabe,et al.  Functional domains of human endothelin receptor. , 1993, Journal of cardiovascular pharmacology.

[37]  R. Miller,et al.  Endothelin receptor heterogeneity; structure activity, autoradiographic and functional studies. , 1991, Journal of receptor research.